Table 2.
Distribution of the Patient-Related Factors and Outcome Variables According to Comprehensive Geriatric Assessment.a,b
Patient-related factors | Total | Comprehensive geriatric assessment | P Value | |
---|---|---|---|---|
N = 1425 | Yes (n=886) | No (n=539) | ||
Age, n (%) | .268 | |||
65-79 | 410 (29) | 247 (28) | 163 (30) | |
80-89 | 759 (53) | 469 (53) | 290 (54) | |
90 or over | 256 (18) | 170 (19) | 86 (16) | |
Sex, n (%) | .707 | |||
Women | 1062 (75) | 657 (74) | 405 (75) | |
Men | 363 (26) | 229 (26) | 134 (25) | |
ASA score, n (%) | .002 | |||
1-3 | 1047 (74) | 672 (76) | 375 (70) | |
4-5 | 354 (25) | 206 (23) | 148 (28) | |
Number of regularly taken medications, n (%) | .097 | |||
< 4 | 247 (17) | 154 (17) | 93 (17) | |
4-10 | 916 (64) | 554 (63) | 362 (67) | |
> 10 | 261 (18) | 177 (20) | 84 (16) | |
BZD-Z | .153 | |||
No | 1033 (73) | 655 (74) | 378 (70) | |
Yes | 391 (27) | 230 (26) | 161 (30) | |
Diagnosis of memory disorder, n (%) | .272 | |||
No | 1038 (73) | 635 (72) | 403 (75) | |
Yes | 379 (27) | 247 (28) | 132 (25) | |
eGFRCKD-EPI, n (%) | .167 | |||
> 60 mL/min/1.73m2 | 821 (58) | 490 (55) | 331 (61) | |
45-59 mL/min/1.73m2 | 287 (29) | 194 (22) | 93 (17) | |
30-44 mL/min/1.73m2 | 193 (14) | 125 (14) | 68 (13) | |
< 30 mL/min/1.73m2 | 87 (6) | 55 (6) | 32 (6) | |
Mobility level, n (%) | .070 | |||
Outdoors unassisted | 743 (52) | 467 (53) | 276 (51) | |
Indoors unassisted | 557 (41) | 354 (40) | 223 (41) | |
Assisted only | 70 (5) | 46 (5) | 24 (5) | |
Unable to walk | 25 (2) | 17 (2) | 8 (2) | |
Living arrangements, n (%) | .002 | |||
Home | 565 (40) | 362 (41) | 203 (38) | |
Home with organized homecare | 399 (28) | 235 (27) | 164 (30) | |
Assisted living accommodation | 237 (17) | 136 (15) | 101 (19) | |
Institutionalized | 213 (15) | 150 (17) | 62 (12) | |
Fracture type, n (%) | .545 | |||
Neck of femur | 886 (62) | 541 (61) | 345 (64) | |
Intertrochanteric | 458 (32) | 292 (33) | 166 (31) | |
Subtrochanteric | 80 (6) | 52 (6) | 28 (5) |
Abbreviations: ASA, American Society of Anesthesiologists; BZD-Z, hypnotic benzodiazepines and z-hypnotics (midazolam, temazepam, nitrazepam, triazolam, zaleplon, zolpidem, and zopiclon); eGFRCKD-EPI, estimated glomerular filtration rate calculated by the Chronic Kidney Disease Epidemiology Collaboration equation.
an = 1425.
bMissing values are not shown but were tested and included in the percentages. Differences between groups were tested by Pearson χ2 test or Fisher exact test. Statistically significant P values (P < .05) are bolded.